Characteristics and outcomes of patients with advanced or metastatic non-small cell lung cancer harboring a HER2-activating mutation: a real-world retrospective cohort study using a US clinico-genomic database.
INTRODUCTION Human epidermal growth factor receptor 2 (HER2/ERBB2) mutated non-small cell lung cancer (NSCLC) is associated with poor prognosis and limited treatment options. METHODS This retrospective cohort study used electronic health records from US academic and community cancer centers to describe characteristic...